Patent_application_number,Applicant_name,Year_of_application,Patent_system
WO2001000030A1,CNRS,2001,WIPO
WO2001000147A1,OREGON STATE (US),2001,WIPO
WO2001000337A1,HOLOGIC INC,2001,WIPO
WO2001000999A1,EBARA CORPORATION,2001,WIPO
WO2001001024A1,UNIVERSITY OF CALIFORNIA,2001,WIPO
WO2001001356A1,CNRS,2001,WIPO
WO2001001614A1,CHEMICO INTERNATIONAL INC,2001,WIPO
WO2001001813A1,GENECOPOEIA,2001,WIPO
WO2001002211A1,UNIVERSITY OF CALIFORNIA,2001,WIPO
WO2001002300A1,INSTITUT PASTEUR,2001,WIPO
WO2001002471A1,CELLDEX,2001,WIPO
WO2001002567A1,MEDIGENE AG (DE),2001,WIPO
WO2001002887A1,AGILENT TECHNOLOGIES,2001,WIPO
WO2001002900A1,ACGT PROGENOMICS,2001,WIPO
WO2001002919A1,VERTEX PHARMACEUTICALS,2001,WIPO
WO2001002942A2,LUDWIG INSTITUTE FOR CANCER RESEARCH,2001,WIPO
WO2001003494A1,UNIVERSITY OF CALIFORNIA,2001,WIPO
WO2001003583A1,ROCHE DIAGNOSTICS,2001,WIPO
WO2001003604A2,"BECTON, DICKINSON AND COMPANY",2001,WIPO
WO2001004447A1,GOVERNMENT OF CHINA,2001,WIPO
WO2001004536A1,BIOSYN ARZNEIMITTEL GMBH (DE),2001,WIPO
WO2001005664A2,PRINCETON UNIVERSITY,2001,WIPO
WO2001005773A1,PRINCETON UNIVERSITY,2001,WIPO
WO2001005971A2,"PHYCOGEN, INC. (US)",2001,WIPO
WO2001006382A1,PROKAZYME,2001,WIPO
WO2001007144A2,ACTIVE BIOTECH AB,2001,WIPO
WO2001007150A2,TAKARA HOLDINGS,2001,WIPO
WO2001007242A1,VERTEX PHARMACEUTICALS,2001,WIPO
WO2001007580A1,PROMEGA CORPORATION,2001,WIPO
WO2001007855A1,"DELTAGEN, INC. (US)",2001,WIPO
WO2001008186A1,INSTITUT PASTEUR,2001,WIPO
WO2001008338A2,THERMO FISHER SCIENTIFIC,2001,WIPO
WO2001008824A1,PROLUME LTD,2001,WIPO
WO2001008829A1,ST. JUDE CHILDREN'S RESEARCH HOSPITAL (US); THE PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US),2001,WIPO
WO2001008865A1,AQUA HEALTH (EUROPE) LIMITED (GB),2001,WIPO
WO2001009091A1,"METABOLIX, INC. (US)",2001,WIPO
WO2001009128A1,BASF,2001,WIPO
WO2001009296A1,BAYER,2001,WIPO
WO2001009347A2,AGILENT TECHNOLOGIES,2001,WIPO
WO2001009348A1,TAKARA HOLDINGS,2001,WIPO
WO2001009458A1,NOVOZYMES,2001,WIPO
WO2001009464A1,NOVOZYMES,2001,WIPO
WO2001009712A1,AKZO NOBEL N.V. (NL),2001,WIPO